Stocks · Health care · Pharmaceutical Preparations

Enliven Therapeutics, Inc.

ELVN Clue Score23
United States Fiscal year ends December CIK 0001672619
40.98
+0.86%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
40.98 on 9 Oct 2026
61 38 15 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $20.68 14 Oct 2025 $20.10 15 Oct 2025 $21.73 16 Oct 2025 $21.75 17 Oct 2025 $21.41 20 Oct 2025 $22.12 21 Oct 2025 $21.19 22 Oct 2025 $20.49 23 Oct 2025 $20.55 24 Oct 2025 $20.61 27 Oct 2025 $21.40 28 Oct 2025 $21.55 29 Oct 2025 $22.65 30 Oct 2025 $23.97 31 Oct 2025 $23.42 3 Nov 2025 $20.00 4 Nov 2025 $19.01 5 Nov 2025 $18.50 6 Nov 2025 $18.30 7 Nov 2025 $17.63 10 Nov 2025 $18.71 11 Nov 2025 $19.64 12 Nov 2025 $20.30 13 Nov 2025 $20.27 14 Nov 2025 $22.07 17 Nov 2025 $21.76 18 Nov 2025 $22.59 19 Nov 2025 $22.10 20 Nov 2025 $21.27 21 Nov 2025 $21.75 24 Nov 2025 $21.77 25 Nov 2025 $21.70 26 Nov 2025 $21.71 28 Nov 2025 $21.60 1 Dec 2025 $19.85 2 Dec 2025 $20.56 3 Dec 2025 $21.00 4 Dec 2025 $21.40 5 Dec 2025 $21.81 8 Dec 2025 $20.52 9 Dec 2025 $19.49 10 Dec 2025 $20.17 11 Dec 2025 $18.77 12 Dec 2025 $16.86 15 Dec 2025 $17.17 16 Dec 2025 $16.91 17 Dec 2025 $16.02 18 Dec 2025 $16.68 19 Dec 2025 $16.87 22 Dec 2025 $17.93 23 Dec 2025 $16.53 24 Dec 2025 $16.73 26 Dec 2025 $16.30 29 Dec 2025 $15.94 30 Dec 2025 $15.55 31 Dec 2025 $15.40 2 Jan 2026 $15.54 5 Jan 2026 $15.21 6 Jan 2026 $15.14 7 Jan 2026 $15.47 8 Jan 2026 $23.25 9 Jan 2026 $26.00 12 Jan 2026 $25.03 13 Jan 2026 $25.75 14 Jan 2026 $26.05 15 Jan 2026 $25.17 16 Jan 2026 $26.71 20 Jan 2026 $27.05 21 Jan 2026 $27.21 22 Jan 2026 $27.03 23 Jan 2026 $25.78 26 Jan 2026 $25.87 27 Jan 2026 $26.16 28 Jan 2026 $25.38 29 Jan 2026 $25.67 30 Jan 2026 $26.45 2 Feb 2026 $28.17 3 Feb 2026 $27.60 4 Feb 2026 $27.82 5 Feb 2026 $26.99 6 Feb 2026 $29.42 9 Feb 2026 $28.08 10 Feb 2026 $27.93 11 Feb 2026 $28.01 12 Feb 2026 $27.16 13 Feb 2026 $26.72 17 Feb 2026 $26.13 18 Feb 2026 $26.37 19 Feb 2026 $26.16 20 Feb 2026 $26.02 23 Feb 2026 $27.45 24 Feb 2026 $28.32 25 Feb 2026 $29.28 26 Feb 2026 $29.62 27 Feb 2026 $29.69 2 Mar 2026 $29.50 3 Mar 2026 $28.75 4 Mar 2026 $29.98 5 Mar 2026 $29.29 6 Mar 2026 $29.44 9 Mar 2026 $29.73 10 Mar 2026 $30.24 11 Mar 2026 $30.70 12 Mar 2026 $28.81 13 Mar 2026 $27.77 16 Mar 2026 $27.39 17 Mar 2026 $27.79 18 Mar 2026 $27.25 19 Mar 2026 $30.05 20 Mar 2026 $29.03 23 Mar 2026 $30.81 24 Mar 2026 $31.15 25 Mar 2026 $35.53 26 Mar 2026 $39.29 27 Mar 2026 $38.83 30 Mar 2026 $36.59 31 Mar 2026 $39.20 1 Apr 2026 $37.79 2 Apr 2026 $38.83 6 Apr 2026 $38.94 7 Apr 2026 $43.16 8 Apr 2026 $42.93 9 Apr 2026 $45.59 10 Apr 2026 $45.32 13 Apr 2026 $43.83 14 Apr 2026 $44.85 15 Apr 2026 $43.95 16 Apr 2026 $45.34 17 Apr 2026 $48.11 20 Apr 2026 $46.41 21 Apr 2026 $45.89 22 Apr 2026 $44.44 23 Apr 2026 $43.89 24 Apr 2026 $44.25 27 Apr 2026 $44.90 28 Apr 2026 $42.98 29 Apr 2026 $42.40 30 Apr 2026 $41.23 1 May 2026 $41.70 4 May 2026 $41.61 5 May 2026 $41.58 6 May 2026 $41.20 7 May 2026 $40.29 8 May 2026 $40.75 11 May 2026 $39.59 12 May 2026 $42.30 13 May 2026 $43.56 14 May 2026 $43.08 15 May 2026 $41.34 18 May 2026 $39.63 19 May 2026 $40.17 20 May 2026 $41.86 21 May 2026 $42.25 22 May 2026 $41.54 26 May 2026 $42.53 27 May 2026 $41.41 28 May 2026 $40.65 29 May 2026 $39.57 1 Jun 2026 $37.51 2 Jun 2026 $35.52 3 Jun 2026 $36.03 4 Jun 2026 $35.49 5 Jun 2026 $34.71 8 Jun 2026 $33.63 9 Jun 2026 $36.11 10 Jun 2026 $37.00 11 Jun 2026 $40.36 12 Jun 2026 $46.13 15 Jun 2026 $42.36 16 Jun 2026 $42.55 17 Jun 2026 $44.86 18 Jun 2026 $45.10 22 Jun 2026 $45.96 23 Jun 2026 $48.60 24 Jun 2026 $47.77 25 Jun 2026 $49.12 26 Jun 2026 $50.08 29 Jun 2026 $50.85 30 Jun 2026 $50.75 1 Jul 2026 $48.76 2 Jul 2026 $49.82 6 Jul 2026 $50.01 7 Jul 2026 $50.92 8 Jul 2026 $50.80 9 Jul 2026 $52.18 10 Jul 2026 $51.09 13 Jul 2026 $50.87 14 Jul 2026 $51.73 15 Jul 2026 $53.16 16 Jul 2026 $50.86 17 Jul 2026 $53.20 20 Jul 2026 $51.67 21 Jul 2026 $54.33 22 Jul 2026 $52.85 23 Jul 2026 $52.81 24 Jul 2026 $52.95 27 Jul 2026 $52.74 28 Jul 2026 $53.76 29 Jul 2026 $52.97 30 Jul 2026 $53.95 31 Jul 2026 $54.81 3 Aug 2026 $58.04 4 Aug 2026 $61.11 5 Aug 2026 $59.70 6 Aug 2026 $60.27 7 Aug 2026 $60.46 10 Aug 2026 $59.42 11 Aug 2026 $58.78 12 Aug 2026 $57.92 13 Aug 2026 $58.06 14 Aug 2026 $58.82 17 Aug 2026 $59.54 18 Aug 2026 $60.07 19 Aug 2026 $59.39 20 Aug 2026 $58.92 21 Aug 2026 $59.82 24 Aug 2026 $61.15 25 Aug 2026 $61.01 26 Aug 2026 $60.87 27 Aug 2026 $60.50 28 Aug 2026 $57.86 31 Aug 2026 $57.89 1 Sep 2026 $57.86 2 Sep 2026 $59.01 3 Sep 2026 $59.65 4 Sep 2026 $59.32 8 Sep 2026 $59.37 9 Sep 2026 $57.45 10 Sep 2026 $56.23 11 Sep 2026 $54.32 14 Sep 2026 $54.43 15 Sep 2026 $53.36 16 Sep 2026 $49.12 17 Sep 2026 $50.24 18 Sep 2026 $49.45 21 Sep 2026 $48.87 22 Sep 2026 $48.19 23 Sep 2026 $46.09 24 Sep 2026 $45.17 25 Sep 2026 $44.75 28 Sep 2026 $46.01 29 Sep 2026 $46.51 30 Sep 2026 $45.84 1 Oct 2026 $46.21 2 Oct 2026 $46.97 5 Oct 2026 $45.47 6 Oct 2026 $42.39 7 Oct 2026 $41.36 8 Oct 2026 $40.63 9 Oct 2026 $40.98 Kintz Samuel PRESIDENT AND CEO Sold on a plan $266.65K 17 Oct 2025 · at $21.33 · 1.4% of stake Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER Sold on a plan $276.03K 20 Oct 2025 · at $22.08 · 1.3% of stake Patel Anish CHIEF OPERATING OFFICER Sold on a plan $116.03K 7 Nov 2025 · at $17.40 · 2.4% of stake Kintz Samuel PRESIDENT AND CEO Sold on a plan $272.74K 17 Nov 2025 · at $21.82 · 1.4% of stake Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER Sold on a plan $279.15K 19 Nov 2025 · at $22.33 · 1.4% of stake Patel Anish CHIEF OPERATING OFFICER Sold on a plan $140.07K 8 Dec 2025 · at $21.02 · 2.5% of stake Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER Sold on a plan $84.21K 19 Dec 2025 · at $16.84 · 0.6% of stake Heyman Richard A. Director Sold on a plan $241.16K 8 Jan 2026 · at $25.03 · 27.4% of stake Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER Sold on a plan $993.44K 8 Jan 2026 · at $24.05 · 4.6% of stake Heyman Richard A. Director Sold on a plan $107.13K 9 Jan 2026 · at $25.00 · 14.6% of stake Patel Anish CHIEF OPERATING OFFICER Sold on a plan $1.35M 9 Jan 2026 · at $27.99 · 18.3% of stake Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER Sold on a plan $2.48M 9 Jan 2026 · at $27.22 · 10.6% of stake Heyman Richard A. Director Sold on a plan $32.90K 20 Jan 2026 · at $26.75 · 4.9% of stake Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER Sold on a plan $535.10K 20 Jan 2026 · at $26.75 · 2.6% of stake Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER Sold on a plan $145.22K 6 Feb 2026 · at $29.04 · 0.7% of stake Heyman Richard A. Director Sold on a plan $32.20K 17 Feb 2026 · at $26.18 · 5.2% of stake Collins Helen Louise CHIEF MEDICAL OFFICER Sold on a plan $1.18M 17 Feb 2026 · at $26.17 · 64.3% of stake Hohl Benjamin CHIEF FINANCIAL OFFICER Sold at will $295.84K 6 Mar 2026 · at $29.58 · 16.4% of stake Collins Helen Louise CHIEF MEDICAL OFFICER Sold on a plan $896.81K 9 Mar 2026 · at $30.02 · 54.4% of stake Collins Helen Louise CHIEF MEDICAL OFFICER Sold on a plan $305.83K 10 Mar 2026 · at $30.19 · 28.8% of stake Collins Helen Louise CHIEF MEDICAL OFFICER Sold on a plan $138.80K 17 Mar 2026 · at $27.76 · 16.7% of stake Collins Helen Louise CHIEF MEDICAL OFFICER Sold on a plan $1.40M 25 Mar 2026 · at $35.10 · 61.5% of stake Collins Helen Louise CHIEF MEDICAL OFFICER Sold on a plan $238.35K 17 Apr 2026 · at $47.67 · 16.7% of stake Collins Helen Louise CHIEF MEDICAL OFFICER Sold on a plan $198.97K 18 May 2026 · at $39.79 · 16.7% of stake Kunkel Lori Anne Director Sold on a plan $345.35K 5 Jun 2026 · at $34.54 · 16.2% of stake ORBIMED ADVISORS LLC 10% owner Sold at will $12.67M 15 Jun 2026 · at $45.02 · 53.4% of stake Collins Helen Louise CHIEF MEDICAL OFFICER Sold on a plan $219.02K 17 Jun 2026 · at $43.80 · 16.7% of stake Hohl Benjamin CHIEF FINANCIAL OFFICER Sold on a plan $263.58K 17 Jun 2026 · at $43.80 · 10.6% of stake ORBIMED ADVISORS LLC 10% owner Sold at will $39.01M 22 Jun 2026 · at $45.36 · 79.7% of stake Kunkel Lori Anne Director Sold on a plan $504.90K 6 Jul 2026 · at $50.49 · 19.3% of stake Collins Helen Louise CHIEF MEDICAL OFFICER Sold on a plan $263.37K 17 Jul 2026 · at $52.67 · 16.7% of stake Hohl Benjamin CHIEF FINANCIAL OFFICER Sold on a plan $316.78K 17 Jul 2026 · at $52.64 · 11.6% of stake Derynck Mika K Director Sold on a plan $9.56M 4 Aug 2026 · at $60.21 · 100% of stake Collins Helen Louise CHIEF MEDICAL OFFICER Sold on a plan $292.93K 17 Aug 2026 · at $58.59 · 16.7% of stake Hohl Benjamin CHIEF FINANCIAL OFFICER Sold on a plan $352.55K 17 Aug 2026 · at $58.58 · 13.1% of stake Collins Helen Louise CHIEF MEDICAL OFFICER Sold on a plan $251.75K 17 Sep 2026 · at $50.35 · 16.7% of stake Hohl Benjamin CHIEF FINANCIAL OFFICER Sold on a plan $303.00K 17 Sep 2026 · at $50.35 · 13.7% of stake Garland J. Scott Director Sold at will $606.72K 1 Oct 2026 · at $46.67 · 100% of stake
0 buys4 sales at will34 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Net income
$103.69M
Free cash flow
$70.46M
Return on equity
-22.6%
Return on capital
-20.6%

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
0K -41M FY20 Fiscal year 2020 Revenue $0.00 Net income $41.36M Margin n/a 0K -51M FY21 Fiscal year 2021 Revenue $0.00 Net income $51.38M Margin n/a 0K -38M FY22 Fiscal year 2022 Revenue $0.00 Net income $37.66M Margin n/a 0K -72M FY23 Fiscal year 2023 Revenue $0.00 Net income $71.58M Margin n/a 0K -89M FY24 Fiscal year 2024 Revenue $0.00 Net income $89.02M Margin n/a 0K -104M FY25 Fiscal year 2025 Revenue $0.00 Net income $103.69M Margin n/a
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
1 Oct 2026 Garland J. Scott
Director
Sold at will $606.72K 100%
17 Sep 2026 Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sold on a plan $303.00K 13.7%
17 Sep 2026 Collins Helen Louise
CHIEF MEDICAL OFFICER
Sold on a plan $251.75K 16.7%
17 Aug 2026 Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sold on a plan $352.55K 13.1%
17 Aug 2026 Collins Helen Louise
CHIEF MEDICAL OFFICER
Sold on a plan $292.93K 16.7%
4 Aug 2026 Derynck Mika K
Director
Sold on a plan $9.56M 100%